DTI-MHAPR:通过PCA增强的功能和异质图表注意力网络来优化药物向相互作用预测
Guang Yang1, Yinbo Liu1, Sijian Wen1
1School of Information and Artificial Intelligence, Anhui Agricultural University, Changjiang West Road, Hefei, 230036, Anhui, China.
BMC bioinformatics
|January 12, 2025
概括
这项研究引入了一种新的图形网络,通过减少冗余特征和增强特征提取来改善药物向相互作用预测. 该方法显著提高了准确性,为药物发现提供了一个新的工具.
科学领域:
- 生物信息学是一种生物信息学.
- 计算化学计算化学
- 药物发现 药物发现 药物发现
背景情况:
- 准确的药物向相互作用 (DTI) 识别对于加速药物发现至关重要.
- 现有的DTI预测方法经常因特征冗余和药物/目标信息的不足利用而扎.
- 需要先进的计算方法来提高DTI预测的准确性和效率.
研究的目的:
- 开发一种新的计算框架,以提高药物向相互作用预测的准确性.
- 通过消除冗余特征和利用拓结构来解决现有方法的局限性.
- 为了更强大的DTI识别,有效地整合多式联运功能.
主要方法:
- 使用各种药物和目标相似度指标构建了一个异质图.
- 使用图形神经网络 (GNN) 来编码图形信息并生成表示向量.
- 整合表示向量和应用主要组件分析 (PCA) 用于特征蒸.
- 利用随机森林算法对DTI进行最终解码和预测.
主要成果:
- 拟议的PCA增强的多层异质图形网络与六个基线DTI预测模型相比,显示出更高的准确性.
- 广泛的实验,包括剥离研究和结果可视化,验证了框架的有效性.
- 该方法成功地集成了多式联运特征,增强了特征提取和可解释性.
结论:
- 开发的基于图形的网络在药物向相互作用预测准确度方面取得了重大进展.
- 该方法有效地处理特征冗余,并通过PCA和GNN增强特征提取.
- 这种新的框架为加速药物发现和开发提供了有价值和可解释的工具.
相关概念视频
02:04Protein-protein Interfaces
12.4K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
12.4K
02:26Protein Networks
3.9K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
3.9K
01:26Drug Discovery: Overview
7.4K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.4K
01:26Targets for Drug Action: Overview
6.0K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.0K
01:28Structure-Activity Relationships and Drug Design
493
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
493
01:28Drug-Receptor Interaction: Antagonist
2.7K
An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
Antagonists can be classified as competitive or noncompetitive based on their...
2.7K